HomeStartups & VentureArticle
Startups · Biztoc.com

Trellis Bioscience secures Series C financing for TRL1068 trial

By finance.yahoo.comJuly 17, 2026 · 1 min read

Trellis Bioscience has closed a $9m Series C funding round to support the completion of its ongoing Phase II clinical trial evaluating calpurbatug (TRL1068), a monoclonal antibody candidate for chronic prosthetic joint infections (PJI). The ongoing trial is b…

Trellis Bioscience has closed a $9m Series C funding round to support the completion of its ongoing Phase II clinical trial evaluating calpurbatug (TRL1068), a monoclonal antibody candidate for chron…

Startups & Venture
Startups · Biztoc.com
The Sovereign Post
■ More from Startups & Venture